NCT00526396 2023-03-24
STAD-1
National Cancer Institute, Naples
Phase 3 Unknown
Clinical Trials
13 trialsNCT03711305 2022-04-18
Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Unknown
NCT04691063 2021-02-26
The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC.
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Unknown
NCT04490421 2021-02-08
Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer.
Fuzhou General Hospital
Phase 3 Unknown
NCT04500145 2021-02-01
Simultaneous Integrated Boost vs. Routine IMRT in Limited-stage Small-cell Lung Cancer
ChineseAMS
Phase 3 Unknown
NCT04535739 2020-09-02
PCI for Patients With ES-SCLC After RCT:a Prospective Randomized Study
ChineseAMS
Phase 3 Unknown
NCT04073550 2019-08-29
Study of Anlotinib Hydrochloride Capsule in Subjects With Small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3 Unknown
NCT03651219 2018-08-29
Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung Cancer
Beijing Chest Hospital
Phase 3 Unknown
NCT02875457 2016-08-24
Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin
Third Military Medical University
Phase 3 Unknown
NCT01460472 2016-07-29
Immunotherapy With Racotumomab in Advanced Lung Cancer
Recombio SL
Phase 3 Unknown
NCT02738346 2016-04-25
CBPC
University Hospital, Angers
Phase 3 Unknown
NCT01555710 2013-05-21
Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)
Alaunos Therapeutics
Phase 3 Unknown
NCT00465491 2009-04-14
SPEAR
Poniard Pharmaceuticals
Phase 3 Unknown